Free Trial
ASX:PNV

PolyNovo (PNV) Stock Price, News & Analysis

PolyNovo logo

About PolyNovo Stock (ASX:PNV)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
3.38 million shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
6.86%
Price Target
N/A
Consensus Rating
N/A

Company Overview

PolyNovo Limited develops medical devices in the United States, Australia, New Zealand, the United Kingdom, Ireland, Singapore, and internationally. The company offers NovoSorb Biodegradable Temporising Matrix, which is used in a fully debrided clean surgical wound to physiologically close the wound. It is also developing hernia devices for hernia repair and solution for ventral hernia and complex abdominal wall reconstruction; NovoSorb Dermal Beta Cell Implant to host pancreatic islet cells in the skin; NovoSorb MTX for the treatment of varying complex wounds; and plastics and reconstructive device product. The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014. PolyNovo Limited was incorporated in 1998 and is headquartered in Port Melbourne, Australia.

Receive PNV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PolyNovo and its competitors with MarketBeat's FREE daily newsletter.

PNV Stock News Headlines

Polynovo Ltd. PNV (Australia: Sydney)
Free Ebook shares Tesla’s roadmap to $500 a share
Even though shares of Tesla are only up 3% this year, one man believes Tesla’s next bull run is just around the corner. In his professional opinion, the share price could reach $500 or more… Now, we understand that may seem far-fetched, but as you’ll see in his new ebook, it’s not as crazy as it may sound. In fact, he argues a Trump presidency could make it happen much faster than you might think. which is why we’re emailing you now… For the time being, he’s giving away his Tesla ebook for free. Inside explains how shares could reach $500 in the near future.
3 ASX Growth Stocks With Insider Ownership Up To 33%
See More Headlines

PNV Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that PolyNovo investors own include Align Technology (ALGN), Amgen (AMGN), DocuSign (DOCU), Panoramic Resources (PAN), Palantir Technologies (PLTR), Plug Power (PLUG) and Roku (ROKU).

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
237
Year Founded
N/A

Profitability

Net Income
$5.26 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$103.23 million
Book Value
A$0.10 per share

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
1.67
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (ASX:PNV) was last updated on 11/14/2024 by MarketBeat.com Staff
From Our Partners